Firstly, we investigated the expression of OPN with the survival analyses (overall survival, biochemical relapse-free survival, disease specific survival, distant metastasis-free survival, and progression-free survival) in PCA patients and all the results showed that the high expression of OPN could decrease the survival time. The gene discussed is SPP1; the disease is posterior cortical atrophy.